Poster

Biophysical Characterization Of A Therapeutic mAb And Its Associated Antigen-Binding Fragments

Source: Catalent

Changes during purification, formulation, fill-finish, and distribution can affect protein stability and practically all steps in the manufacturing process may perturb the higher-order structure and heterogeneity of the molecule, thus determining size homogeneity of a monoclonal antibody in solution is important for comparability and characterization of these medications. For this study, an IgG antibody was cleaved into antigen-binding fragments using pepsin and papain digestion, followed by protein purification. The fragments, along with intact mAb, were studied by Sedimentation Velocity-Analytical Ultracentrifugation (SV-AUC) and Size-Exclusion Chromatography Multi-Angle Light Scattering (SEC-MALS) to determine sedimentation coefficient, distribution, and molecular weight of each.

Download the poster to learn more about the results from the study and characterization of size and distribution of the intact mAb and enzymatic fragments.

Key Learning

  • The efficacy of orthogonal approaches, SV-AUC and SEC-MALS
  • Effective characterization of intact antibodies, as well as antibody fragments
  • Overlapping and complementary results provide ideal context for further aggregation studies

VIEW THE POSTER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: